Rethinking the classification of acute status epilepticus: structural brain vs. systemic etiologies

Status epilepticus (SE) is a life-threatening neurological emergency whose modern conceptualization employs a multidimensional framework encompassing semiology, etiology, electroencephalographic features, and age. Among these, the etiological dimension is central, as it captures the underlying pathophysiology and critically informs both acute management and long-term prognosis. Current classifications define acute SE by its temporal proximity to a central nervous system insult, yet this approach groups heterogeneous mechanisms under a single category. Acute SE arising from structural brain injury involves downstream receptor and ionic dysfunction driven by inflammation, neuronal loss, glial activation, and network remodeling. In contrast, systemic etiologies, such as electrolyte disturbances, toxic exposures, or withdrawal states, primarily reflect transient disruptions in excitatoryinhibitory balance or ionic homeostasis. These mechanistic distinctions translate into meaningful clinical differences: structural causes are associated with higher mortality, greater seizure recurrence, and an increased risk of subsequent epilepsy. A more refined etiological classification distinguishing structural from systemic causes could better capture variations in pathophysiology, treatment response, and long-term outcomes. Such a framework may also guide decisions regarding the duration and intensity of antiseizure medication (ASM) therapy, a domain in which evidence remains limited. Whether early and sustained ASM treatment after SE due to structural brain injury can modify epileptogenesis is unknown, as no randomized controlled trials have directly addressed this question. Clarifying etiological subgroups may therefore facilitate targeted clinical and translational studies, improve prognostication, and ultimately support the development of interventions to prevent the transition from acute SE to chronic epilepsy.

Authors

Institutions

Publication Details

Journal
Frontiers in Neurology
Published
2026-01-20
DOI
https://doi.org/10.3389/fneur.2026.1763224
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rethinking the classification of acute status epilepticus: structural brain vs. systemic etiologies

Pia De Stefano, Paola Gullino, Sophie Xhepa
Frontiers in Neurology
Epilepsy research and treatment
article

Rethinking the classification of acute status epilepticus: structural brain vs. systemic etiologies

Pia De Stefano, Paola Gullino, Sophie Xhepa
article en

Abstract

Status epilepticus (SE) is a life-threatening neurological emergency whose modern conceptualization employs a multidimensional framework encompassing semiology, etiology, electroencephalographic features, and age. Among these, the etiological dimension is central, as it captures the underlying pathophysiology and critically informs both acute management and long-term prognosis. Current classifications define acute SE by its temporal proximity to a central nervous system insult, yet this approach groups heterogeneous mechanisms under a single category. Acute SE arising from structural brain injury involves downstream receptor and ionic dysfunction driven by inflammation, neuronal loss, glial activation, and network remodeling. In contrast, systemic etiologies, such as electrolyte disturbances, toxic exposures, or withdrawal states, primarily reflect transient disruptions in excitatoryinhibitory balance or ionic homeostasis. These mechanistic distinctions translate into meaningful clinical differences: structural causes are associated with higher mortality, greater seizure recurrence, and an increased risk of subsequent epilepsy. A more refined etiological classification distinguishing structural from systemic causes could better capture variations in pathophysiology, treatment response, and long-term outcomes. Such a framework may also guide decisions regarding the duration and intensity of antiseizure medication (ASM) therapy, a domain in which evidence remains limited. Whether early and sustained ASM treatment after SE due to structural brain injury can modify epileptogenesis is unknown, as no randomized controlled trials have directly addressed this question. Clarifying etiological subgroups may therefore facilitate targeted clinical and translational studies, improve prognostication, and ultimately support the development of interventions to prevent the transition from acute SE to chronic epilepsy.

Frontiers in NeurologyVol. 17
University of Siena (IT), University of Geneva (CH), University Hospital of Geneva (CH), Geneva College (US)
Good health and well-being
Openalex Percentile: Top 84%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.